IDEAS home Printed from https://ideas.repec.org/r/aea/jeclit/v29y1991i2p523-52.html
   My bibliography  Save this item

The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Michael Alexeev & Ivan Dedyukhin & Leonid Polishchuk, 2024. "Ownership, Asymmetric Information, and Quality of Care for the Elderly: Evidence from US Nursing Homes During the COVID-19 Pandemic," CAEPR Working Papers 2024-006 Classification-, Center for Applied Economics and Policy Research, Department of Economics, Indiana University Bloomington.
  2. Holger Strulik & Volker Grossmann, 2022. "Life Cycle Economics with Infectious and Chronic Diseases," CESifo Working Paper Series 10141, CESifo.
  3. Roel van Elk & Esther Mot & P.H. Franses, 2009. "Modelling health care expenditures; overview of the literature and evidence from a panel time series model," CPB Discussion Paper 121.rdf, CPB Netherlands Bureau for Economic Policy Analysis.
  4. Thomas P. Lyon, 1999. "Quality Competition, Insurance, and Consumer Choice in Health Care Markets," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 8(4), pages 546-580, December.
  5. Frankovic, Ivan & Kuhn, Michael, 2018. "Health insurance, endogenous medical progress, and health expenditure growth," ECON WPS - Working Papers in Economic Theory and Policy 01/2018, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
  6. Daron Acemoglu & Amy Finkelstein, 2008. "Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector," Journal of Political Economy, University of Chicago Press, vol. 116(5), pages 837-880, October.
  7. Laurence Baker & Joanne Spetz, 1999. "Managed Care and Medical Technology Growth," NBER Chapters, in: Frontiers in Health Policy Research, volume 2, pages 27-52, National Bureau of Economic Research, Inc.
  8. Ku, Yu-Chun & Chou, Yiing-Jenq & Lee, Miaw-Chwen & Pu, Christy, 2019. "Effects of National Health Insurance on household out-of-pocket expenditure structure," Social Science & Medicine, Elsevier, vol. 222(C), pages 1-10.
  9. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.
  10. Joseph P. Newhouse, 1998. "US and UK health economics: Two disciplines separated by a common language?," Health Economics, John Wiley & Sons, Ltd., vol. 7(S1), pages 79-92, August.
  11. Liran Einav & Amy Finkelstein & Atul Gupta, 2017. "Is American Pet Health Care (Also) Uniquely Inefficient?," American Economic Review, American Economic Association, vol. 107(5), pages 491-495, May.
  12. Faridah Djellal & Camal Gallouj & Faïz Gallouj, 2004. "De l’hôpital fonction de production à l’hôpital service complexe et nœud de réseau : les différentes facettes de l’innovation hospitalière," Post-Print halshs-01114049, HAL.
  13. Lakdawalla, Darius & Malani, Anup & Reif, Julian, 2017. "The insurance value of medical innovation," Journal of Public Economics, Elsevier, vol. 145(C), pages 94-102.
  14. David M. Cutler, 1994. "A Guide to Health Care Reform," Journal of Economic Perspectives, American Economic Association, vol. 8(3), pages 13-29, Summer.
  15. Richard Cookson & Diane Dawson, 2012. "Hospital Competition and Patient Choice in Publicly Funded Health Care," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 20, Edward Elgar Publishing.
  16. Kurt Hornschild & Stephan Raab & Jörg-Peter Weiß, 2005. "Die Medizintechnik am Standort Deutschland: Chancen und Risiken durch technologische Innovationen, Auswirkungen auf und durch das nationale Gesundheitssystem sowie potentielle Wachstumsmärkte im Ausla," DIW Berlin: Politikberatung kompakt, DIW Berlin, German Institute for Economic Research, edition 2, volume 10, number pbk10.
  17. Casper van Ewijk & Nick Draper & Harry ter Rele & Ed Westerhout, 2006. "Ageing and the sustainability of Dutch public finances," CPB Special Publication 61.rdf, CPB Netherlands Bureau for Economic Policy Analysis.
  18. repec:spo:wpecon:info:hdl:2441/4303 is not listed on IDEAS
  19. repec:spo:wpmain:info:hdl:2441/4303 is not listed on IDEAS
  20. Murthy, Vasudeva N.R. & Okunade, Albert A., 2016. "Determinants of U.S. health expenditure: Evidence from autoregressive distributed lag (ARDL) approach to cointegration," Economic Modelling, Elsevier, vol. 59(C), pages 67-73.
  21. Schnittker, Jason & Karandinos, George, 2010. "Methuselah's medicine: Pharmaceutical innovation and mortality in the United States, 1960-2000," Social Science & Medicine, Elsevier, vol. 70(7), pages 961-968, April.
  22. Vasanthakumar Bhat, 2005. "Institutional arrangements and efficiency of health care delivery systems," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(3), pages 215-222, September.
  23. Schreyögg, Jonas, 2002. "Medical Savings Accounts als Instrument zur Reduktion von moral hazard Verlusten bei der Absicherung des Krankheitsrisikos," Discussion Papers 2002/5, Technische Universität Berlin, School of Economics and Management.
  24. Justin Polchlopek, 2011. "Medical Expenditure Growth and the Diffusion of Medical Technology," Working Paper Series, Department of Economics, University of Utah 2011_10, University of Utah, Department of Economics.
  25. Gilad Sorek, 2006. "Advancing Medical Technology, Aging Population, and Economic Growth," DEGIT Conference Papers c011_046, DEGIT, Dynamics, Economic Growth, and International Trade.
  26. Garcia-Goni, Manuel & Maroto, Andres & Rubalcaba, Luis, 2007. "Innovation and motivation in public health professionals," Health Policy, Elsevier, vol. 84(2-3), pages 344-358, December.
  27. Gertler, Paul J., 1998. "On the road to social health insurance: the Asian experience," World Development, Elsevier, vol. 26(4), pages 717-732, April.
  28. Boyer, Robert, 2015. "L’essor du secteur de la santé annonce-t-il un modèle de développement anthropogénétique ?," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
  29. Faridah Djellal & Faïz Gallouj, 2007. "Innovation in hospitals: a survey of the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(3), pages 181-193, September.
  30. Edgar A. Peden & Mark S. Freeland, 1998. "Insurance effects on US medical spending (1960–1993)," Health Economics, John Wiley & Sons, Ltd., vol. 7(8), pages 671-687, December.
  31. Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015. "Public health insurance expansions and hospital technology adoption," Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
  32. Sorenson, Corinna & Drummond, Michael & Bhuiyan Kahn, Beena, 2013. "Medical technology as a key driver of rising health expenditures: disentangling the relationship," LSE Research Online Documents on Economics 48043, London School of Economics and Political Science, LSE Library.
  33. Xidong Guo, 2024. "An analysis of a rural hospital's investment decision under different payment systems," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 714-747, April.
  34. David M. Cutler, 2002. "Equality, Efficiency, and Market Fundamentals: The Dynamics of International Medical-Care Reform," Journal of Economic Literature, American Economic Association, vol. 40(3), pages 881-906, September.
  35. Olatunji A. Shobande & Lawrence Ogbeifun & Simplice A. Asongu, 2022. "Globalisation, technology and global health," Working Papers 22/070, European Xtramile Centre of African Studies (EXCAS).
  36. Jeffrey Clemens & Joshua D. Gottlieb, 2014. "Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?," American Economic Review, American Economic Association, vol. 104(4), pages 1320-1349, April.
  37. Pedro Pita Barros & Xavier Martínez-Giralt, 2009. "Technological adoption in health care," Working Papers 413, Barcelona School of Economics.
  38. Kees Folmer & Johnny Stevens & Frank Van Tulder & Ed Westerhout, 1997. "Towards an economic model of the Dutch health care sector," Health Economics, John Wiley & Sons, Ltd., vol. 6(4), pages 351-363, July.
  39. Kristopher J. Hult & Tomas J. Philipson, 2012. "Public Liabilities and Health Care Policy," NBER Working Papers 18571, National Bureau of Economic Research, Inc.
  40. Kristopher J. Hult & Sonia Jaffe & Tomas J. Philipson, 2018. "How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations," American Journal of Health Economics, University of Chicago Press, vol. 4(4), pages 433-453, Fall.
  41. Jeffrey Clemens, 2012. "The Effect of U.S. Health Insurance Expansions on Medical Innovation," Discussion Papers 11-016, Stanford Institute for Economic Policy Research.
  42. Bryane Michael, 2018. "What does Brunei teach us about using Human Development Index rankings as a policy tool?," Development Policy Review, Overseas Development Institute, vol. 36(S1), pages 414-431, March.
  43. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2017. "The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 333-358, September.
  44. Galizzi, Matteo M. & Miraldo, Marisa, 2011. "The effects of hospitals' governance on optimal contracts: Bargaining vs. contracting," Journal of Health Economics, Elsevier, vol. 30(2), pages 408-424, March.
  45. Eswaran, Mukesh & Gallini, Nancy, 2016. "Rescuing the Golden Age of Antibiotics: Can Economics Help Avert the Looming Crisis?," Economics working papers nancy_gallini-2016-9, Vancouver School of Economics, revised 04 Jul 2016.
  46. Robert F. Graboyes, 2000. "Getting better, feeling worse : cure rates, health insurance, and welfare," Working Paper 00-05, Federal Reserve Bank of Richmond.
  47. Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2016. "The design of insurance coverage for medical products under imperfect competition," Journal of Public Economics, Elsevier, vol. 137(C), pages 28-37.
  48. Amy Finkelstein, 2005. "The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare," NBER Working Papers 11619, National Bureau of Economic Research, Inc.
  49. Karine Lamiraud & Stephane Lhuillery, 2016. "Endogenous Technology Adoption and Medical Costs," Health Economics, John Wiley & Sons, Ltd., vol. 25(9), pages 1123-1147, September.
  50. Windrum, Paul & Garci­a-Goñi, Manuel, 2008. "A neo-Schumpeterian model of health services innovation," Research Policy, Elsevier, vol. 37(4), pages 649-672, May.
  51. Jorge Elgart & Joaquin Caporale & Lorena Gonzalez & Eleonora Aiello & Maximiliano Waschbusch & Juan Gagliardino, 2013. "Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina," Health Economics Review, Springer, vol. 3(1), pages 1-9, December.
  52. Paolo Pertile, 2008. "Investment in Health Technologies in a Competitive Model with Real Options," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 10(5), pages 923-952, October.
  53. Shishu Zhang & Gregory J. Soukup, 2015. "Factors that influence the selection and utilization of children’s medical insurance," Cogent Business & Management, Taylor & Francis Journals, vol. 2(1), pages 1010882-101, December.
  54. Muzhe Yang & Hsien-Ming Lien & Shin-Yi Chou, 2014. "Is There A Physician Peer Effect? Evidence From New Drug Prescriptions," Economic Inquiry, Western Economic Association International, vol. 52(1), pages 116-137, January.
  55. Böhm, Sebastian & Grossmann, Volker & Strulik, Holger, 2021. "R&D-driven medical progress, health care costs, and the future of human longevity," The Journal of the Economics of Ageing, Elsevier, vol. 18(C).
  56. Shin‐Yi Chou & Jin‐Tan Liu & James K. Hammitt, 2004. "National Health Insurance and Technology Adoption: Evidence from Taiwan," Contemporary Economic Policy, Western Economic Association International, vol. 22(1), pages 26-38, January.
  57. Khwaja, Ahmed, 2010. "Estimating willingness to pay for medicare using a dynamic life-cycle model of demand for health insurance," Journal of Econometrics, Elsevier, vol. 156(1), pages 130-147, May.
  58. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," NBER Working Papers 14257, National Bureau of Economic Research, Inc.
  59. Djellal, Faridah & Gallouj, FaIz, 2005. "Mapping innovation dynamics in hospitals," Research Policy, Elsevier, vol. 34(6), pages 817-835, August.
  60. Han, Kyu-Tae & Park, Eun-Cheol & Kim, Sun Jung & Kim, Woorim & Hahm, Myung-Il & Jang, Sung-In & Lee, Sang Gyu, 2015. "Effective strategy for improving health care outcomes: Multidisciplinary care in cerebral infarction patients," Health Policy, Elsevier, vol. 119(8), pages 1039-1045.
  61. Wasem, Jurgen, 1997. "A study on decentralizing from acute care to home care settings in Germany," Health Policy, Elsevier, vol. 41(Supplemen), pages 109-129, September.
  62. Mickael Bech & Terkel Christiansen & Kelly Dunham & Jørgen Lauridsen & Carl Hampus Lyttkens & Kathryn McDonald & Alistair McGuire & and the TECH Investigators, 2009. "The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat heart attacks," Health Economics, John Wiley & Sons, Ltd., vol. 18(10), pages 1114-1132, October.
  63. Nicolas Couderc & Bruno Ventelou & Vincent Touzé, 2001. "Politiques de santé dans un modèle macroéconomique," Post-Print hal-03428452, HAL.
  64. Karine Lamiraud & Stéphane Lhuillery, 2015. "Endogenous Technology Adoption and Medical Costs," Working Papers hal-01218064, HAL.
  65. Dranove, David & Garthwaite, Craig & Heard, Christopher & Wu, Bingxiao, 2022. "The economics of medical procedure innovation," Journal of Health Economics, Elsevier, vol. 81(C).
  66. Bardey, D. & Bommier, A. & Jullien, B., 2010. "Retail price regulation and innovation: Reference pricing in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 29(2), pages 303-316, March.
  67. Amitabh Chandra & Jonathan Skinner, 2012. "Technology Growth and Expenditure Growth in Health Care," Journal of Economic Literature, American Economic Association, vol. 50(3), pages 645-680, September.
  68. Frankovic, Ivan & Kuhn, Michael, 2023. "Health insurance, endogenous medical progress, health expenditure growth, and welfare," Journal of Health Economics, Elsevier, vol. 87(C).
  69. Simon Eckermann & Tim Coelli, 2008. "Including quality attributes in a model of health care efficiency: A net benefit approach," CEPA Working Papers Series WP032008, School of Economics, University of Queensland, Australia.
  70. Okunade, Albert A. & Suraratdecha, Chutima, 2006. "The pervasiveness of pharmaceutical expenditure inertia in the OECD countries," Social Science & Medicine, Elsevier, vol. 63(1), pages 225-238, July.
  71. Stern, S. & Trajtenberg, M., 1998. "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," Papers 24-98, Tel Aviv.
  72. Anupam B. Jena & Stéphane Mechoulan & Tomas J. Philipson, 2010. "Altruism and Innovation in Health Care," Journal of Law and Economics, University of Chicago Press, vol. 53(3), pages 497-518.
  73. Jos L. T. Blank & Vivian G. Valdmanis, 2015. "Technology diffusion in hospitals: a log odds random effects regression model," International Journal of Health Planning and Management, Wiley Blackwell, vol. 30(3), pages 246-259, July.
  74. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2014. "The Impact of Health Insurance Expansion on Physician Treatment Choice: Medicare Part D and Physician Prescribing," NBER Working Papers 20708, National Bureau of Economic Research, Inc.
  75. Walter M. Cadette, 1996. "Rethinking Health Care Policy: The Case for Retargeting Tax Subsidies," Economics Working Paper Archive wp_171, Levy Economics Institute.
  76. Roger D. Congleton & Alberto Batinti & Rinaldo Pietratonio, 2017. "The Electoral Politics and the Evolution of Complex Healthcare Systems," Kyklos, Wiley Blackwell, vol. 70(4), pages 483-510, November.
  77. Wigger, Berthold U. & Anlauf, Markus, 2002. "Moral Hazard, Market Power, and Second Best Health Insurance," CSLE Discussion Paper Series 2002-06, Saarland University, CSLE - Center for the Study of Law and Economics.
  78. Po-Chin Wu & Shiao-Yen Liu & Sheng-Chieh Pan, 2014. "Nonlinear relationship between health care expenditure and its determinants: a panel smooth transition regression model," Empirica, Springer;Austrian Institute for Economic Research;Austrian Economic Association, vol. 41(4), pages 713-729, November.
  79. Thomas Grebel, 2011. "Innovation and Health," Books, Edward Elgar Publishing, number 14375.
  80. Kesteloot, K. & Voet, N., 1998. "Incentives for cooperation in quality improvement among hospitals--the impact of the reimbursement system," Journal of Health Economics, Elsevier, vol. 17(6), pages 701-728, December.
  81. Alice Chen & Dana Goldman, 2016. "Health Care Spending: Historical Trends and New Directions," Annual Review of Economics, Annual Reviews, vol. 8(1), pages 291-319, October.
  82. Robert E. Hall & Charles I. Jones, 2007. "The Value of Life and the Rise in Health Spending," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 122(1), pages 39-72.
  83. Seungchul Lee & Robert Rosenman, 2013. "Reimbursement and Investment: Prospective Payment and For-Profit Hospitals’ Market Share," Journal of Industry, Competition and Trade, Springer, vol. 13(4), pages 503-518, December.
  84. Lakomaa, Erik & Sanandaji, Tino, 2017. "Integrating community driven care service in European welfare states – nonprofit institutional entrepreneurship as driver for expanding access," SSE Working Paper Series in Economic History 2017:5, Stockholm School of Economics.
  85. repec:hal:wpspec:info:hdl:2441/4303 is not listed on IDEAS
  86. Usha Reichert & Richard Cebula, 1999. "A note on health care inflation," Journal of Economics and Finance, Springer;Academy of Economics and Finance, vol. 23(3), pages 193-198, September.
  87. Stéphane Jacobzone, 1997. "Systèmes mixtes d'assurance maladie, équité, gestion du risque et maîtrise des coûts," Économie et Prévision, Programme National Persée, vol. 129(3), pages 189-205.
  88. Sanandaji, Tino & Lakomaa, Erik, 2016. "Care, Commons and Entrepreneurship," SSE Working Paper Series in Economic History 2016:2, Stockholm School of Economics.
  89. Elisabet Rodriguez Llorian & Janelle Mann, 2022. "Exploring the technology–healthcare expenditure nexus: a panel error correction approach," Empirical Economics, Springer, vol. 62(6), pages 3061-3086, June.
  90. Rune Stenbacka & Mihkel Tombak, 2014. "Optimal Co-Payment Policy In Health Care: Competition, Ownership Structure And Quality Provision," Working Papers 140004, Canadian Centre for Health Economics.
  91. David M. Cutler & Ellen Meara & Seth Richards-Shubik, 2012. "Induced Innovation and Social Inequality: Evidence from Infant Medical Care," Journal of Human Resources, University of Wisconsin Press, vol. 47(2), pages 456-492.
  92. Aaron Schwartz & Roger Magoulas & Melinda Buntin, 2013. "Tracking Labor Demand with Online Job Postings: The Case of Health IT Workers and the HITECH Act," Industrial Relations: A Journal of Economy and Society, Wiley Blackwell, vol. 52(4), pages 941-968, October.
  93. Cutler, David M. & Huckman, Robert S., 2003. "Technological development and medical productivity: the diffusion of angioplasty in New York state," Journal of Health Economics, Elsevier, vol. 22(2), pages 187-217, March.
  94. Victor R. Fuchs, 1996. "Introduction to "Individual and Social Responsibility: Child Care, Education, Medical Care, and Long-Term Care in America"," NBER Chapters, in: Individual and Social Responsibility: Child Care, Education, Medical Care, and Long-Term Care in America, pages 1-12, National Bureau of Economic Research, Inc.
  95. Peter Willemé & Michel Dumont, 2016. "Machines that go ‘ping’: Medical Technology and Health Expenditures in OECD Countries," Health Economics, John Wiley & Sons, Ltd., vol. 25(3), pages 387-388, March.
  96. Laurence C. Baker, 2000. "Managed Care and Technology Adoption in Health Care: Evidence from Magnetic Resonance Imaging," NBER Working Papers 8020, National Bureau of Economic Research, Inc.
  97. Stan Veuger & Jeffrey Clemens, 2015. "Innovation and uncertainty in the medical industry: Evidence from the case of Myriad Genetics, Inc," AEI Economics Working Papers 834894, American Enterprise Institute.
  98. Randall P. Ellis & Thomas G. McGuire, 1993. "Supply-Side and Demand-Side Cost Sharing in Health Care," Journal of Economic Perspectives, American Economic Association, vol. 7(4), pages 135-151, Fall.
  99. Chalkley, Martin & Malcomson, James M., 2002. "Cost sharing in health service provision: an empirical assessment of cost savings," Journal of Public Economics, Elsevier, vol. 84(2), pages 219-249, May.
  100. Joseph P. Newhouse, 1992. "Medical Care Costs: How Much Welfare Loss?," Journal of Economic Perspectives, American Economic Association, vol. 6(3), pages 3-21, Summer.
  101. Okunade, Albert A., 2004. "Concepts, measures, and models of technology and technical progress in medical care and health economics," The Quarterly Review of Economics and Finance, Elsevier, vol. 44(3), pages 363-368, July.
  102. Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
  103. Thomas E. Getzen & Albert A. Okunade, 2017. "Symposium Introduction: Papers on ‘Modeling National Health Expenditures’," Health Economics, John Wiley & Sons, Ltd., vol. 26(7), pages 827-833, July.
  104. Batinti, Alberto & Congleton, Roger D., 2018. "On the codetermination of tax-financed medical R&D and healthcare expenditures: Models and evidence," European Journal of Political Economy, Elsevier, vol. 54(C), pages 175-188.
  105. Jacques H. Drèze, 1997. "Sur la spécificité économique des soins de santé," Économie et Prévision, Programme National Persée, vol. 129(3), pages 1-9.
  106. Michael C. Christensen & Dahlia Remler, 2007. "Information and Communications Technology in Chronic Disease Care: Why is Adoption So Slow and Is Slower Better?," NBER Working Papers 13078, National Bureau of Economic Research, Inc.
  107. Jonathan Gruber, 1992. "The Effect of Price Shopping in Medical Markets: Hospital Responses to PPOs in California," NBER Working Papers 4190, National Bureau of Economic Research, Inc.
  108. Junqiang Han & Xiaodong Zhang & Yingying Meng, 2020. "The Impact of Internet Medical Information Overflow on Residents’ Medical Expenditure Based on China’s Observations," IJERPH, MDPI, vol. 17(10), pages 1-16, May.
  109. Bahram Adrangi & Kambiz Raffiee, 1997. "An econometric analysis of health care reform in the U.S," International Advances in Economic Research, Springer;International Atlantic Economic Society, vol. 3(2), pages 181-192, May.
  110. Jeffrey Clemens & Stan Veuger, 2017. "Risks To The Returns To Medical Innovation: The Case Of Myriad Genetics," Contemporary Economic Policy, Western Economic Association International, vol. 35(2), pages 345-357, April.
  111. Farasat A.S. Bokhari, 2001. "Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catheterization," HEW 0110001, University Library of Munich, Germany.
  112. Ma, Ching-To Albert & McGuire, Thomas G, 1993. "Paying for Joint Costs in Health Care," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 2(1), pages 71-95, Spring.
  113. Eswaran, Mukesh & Gallini, Nancy, 2017. "Can Competition Extend the Golden Age of Antibiotics?," Microeconomics.ca working papers -2017-9, Vancouver School of Economics, revised 19 Oct 2017.
  114. Laurence C. Baker & Ciaran S. Phibbs, 2000. "Managed Care, Technology Adoption, and Health Care: The Adoption of Neonatal Intensive Care," NBER Working Papers 7883, National Bureau of Economic Research, Inc.
  115. Chakroun, Mohamed, 2009. "Health care expenditure and GDP: An international panel smooth transition approach," MPRA Paper 14322, University Library of Munich, Germany.
  116. McGuire Thomas G., 2014. "A Note on Income Effects and Health Care Cost Growth in Medicare," Forum for Health Economics & Policy, De Gruyter, vol. 17(1), pages 1-12, January.
  117. Dominique Bureau & Geneviève Plu-Bureau & Jean-Christophe Thalabard, 1993. "L'évaluation économique des traitements médicaux : méthodes et enjeux," Économie et Statistique, Programme National Persée, vol. 266(1), pages 65-75.
  118. McClellan, Mark & Skinner, Jonathan, 2006. "The incidence of Medicare," Journal of Public Economics, Elsevier, vol. 90(1-2), pages 257-276, January.
  119. Molly Frean & Mark Pauly, 2018. "Does High Cost-Sharing Slow the Long-term Growth Rate of Health Spending? Evidence from the States," NBER Working Papers 25156, National Bureau of Economic Research, Inc.
  120. repec:dau:papers:123456789/7972 is not listed on IDEAS
  121. Rudy Douven & E. Schut, 2006. "Health plan pricing behaviour and managed competition," CPB Discussion Paper 61.rdf, CPB Netherlands Bureau for Economic Policy Analysis.
  122. Ellison, Sara Fisher & Mullin, Wallace P, 2001. "Gradual Incorporation of Information: Pharmaceutical Stocks and the Evolution of President Clinton's Health Care Reform," Journal of Law and Economics, University of Chicago Press, vol. 44(1), pages 89-129, April.
  123. Mark Blaug, 1998. "Where are we now in British health economics?," Health Economics, John Wiley & Sons, Ltd., vol. 7(S1), pages 63-78, August.
  124. Marisa Miraldo, 2007. "Hospital Financing and the Development and Adoption of New Technologies," Working Papers 026cherp, Centre for Health Economics, University of York.
  125. Kamil Dybczak & Bartosz Przywara, 2010. "The role of technology in health care expenditure in the EU," European Economy - Economic Papers 2008 - 2015 400, Directorate General Economic and Financial Affairs (DG ECFIN), European Commission.
  126. Cox, James C. & Sadiraj, Vjollca & Schnier, Kurt E. & Sweeney, John F., 2016. "Higher quality and lower cost from improving hospital discharge decision making," Journal of Economic Behavior & Organization, Elsevier, vol. 131(PB), pages 1-16.
  127. Jun Li, 2022. "Value‐Based Payments in Health Care: Evidence from a Nationwide Randomized Experiment in the Home Health Sector," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 41(4), pages 1090-1117, September.
  128. Hofmarcher, Maria M., 1999. "Cross-Section Analysis of Health Spending with Special Regard to Trends in Austria," Economics Series 70, Institute for Advanced Studies.
  129. Okunade, Albert A. & Murthy, Vasudeva N. R., 2002. "Technology as a 'major driver' of health care costs: a cointegration analysis of the Newhouse conjecture," Journal of Health Economics, Elsevier, vol. 21(1), pages 147-159, January.
  130. Hofmarcher, Maria M. & Festl, Eva & Bishop-Tarver, Leslie, 2016. "Health sector employment growth calls for improvements in labor productivity," Health Policy, Elsevier, vol. 120(8), pages 894-902.
  131. Gianluca Baio & Laura Magazzini & Claudia Oglialoro & Fabio Pammolli & Massimo Riccaboni, 2005. "Medical Devices: Competitiveness and Impact on Public Health Expenditure," Working Papers CERM 05-2005, Competitività, Regole, Mercati (CERM).
  132. Katherine Baicker & Amitabh Chandra, 2011. "Aspirin, angioplasty and proton beam therapy: the economics of smarter health-care spending," Proceedings - Economic Policy Symposium - Jackson Hole, Federal Reserve Bank of Kansas City, pages 197-235.
  133. Rosella Levaggi, 2007. "Regulating internal markets for hospital care," Journal of Regulatory Economics, Springer, vol. 32(2), pages 173-193, October.
  134. Roel van Elk & Esther Mot & P.H. Franses, 2009. "Modelling health care expenditures; overview of the literature and evidence from a panel time series model," CPB Discussion Paper 121, CPB Netherlands Bureau for Economic Policy Analysis.
  135. Magnus Lindelow, 2004. "Understanding spatial variation in the utilization of health," Development and Comp Systems 0409058, University Library of Munich, Germany.
  136. Sherry Glied, 2003. "Health Care Costs: On the Rise Again," Journal of Economic Perspectives, American Economic Association, vol. 17(2), pages 125-148, Spring.
  137. Baker, Laurence C., 2001. "Managed care and technology adoption in health care: evidence from magnetic resonance imaging," Journal of Health Economics, Elsevier, vol. 20(3), pages 395-421, May.
  138. Marwa Farag & A. NandaKumar & Stanley Wallack & Dominic Hodgkin & Gary Gaumer & Can Erbil, 2012. "The income elasticity of health care spending in developing and developed countries," International Journal of Health Economics and Management, Springer, vol. 12(2), pages 145-162, June.
  139. Joseph P. Newhouse, 1994. "Symposium on Health Care Reform," Journal of Economic Perspectives, American Economic Association, vol. 8(3), pages 3-11, Summer.
  140. Chapin White, 2006. "The Slowdown in Medicare Spending Growth: Working Paper 2006-08," Working Papers 18017, Congressional Budget Office.
  141. Bloom, David E. & Kuhn, Michael & Prettner, Klaus, 2018. "Health and Economic Growth," IZA Discussion Papers 11939, Institute of Labor Economics (IZA).
  142. Okunade, Albert A. & Osmani, Ahmad Reshad, 2018. "Technology, Productivity, and Costs in Healthcare," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, pages 1-21.
  143. M. Martin Boyer & Pierre-Thomas Léger, 2001. "Inflation as a Strategic Response," CIRANO Working Papers 2001s-26, CIRANO.
  144. repec:hal:cepnwp:hal-01111804 is not listed on IDEAS
  145. Eduardo da Motta e Albuquerque & José Eduardo Cassiolato, 2001. "Less-developed countries and innovation in health: notes and data about the Brazilian case," Textos para Discussão Cedeplar-UFMG td156, Cedeplar, Universidade Federal de Minas Gerais.
  146. Charles I. Jones, 2002. "Why Have Health Expenditures as a Share fo GDP Risen So Much?," NBER Working Papers 9325, National Bureau of Economic Research, Inc.
  147. Patricia M. Danzon & Mark V. Pauly, 2002. "Health Insurance and the Growth in Pharmaceutical Expenditures," Journal of Law and Economics, University of Chicago Press, vol. 45(S2), pages 587-613.
  148. Jobjörnsson, Sebastian & Forster, Martin & Pertile, Paolo & Burman, Carl-Fredrik, 2016. "Late-stage pharmaceutical R&D and pricing policies under two-stage regulation," Journal of Health Economics, Elsevier, vol. 50(C), pages 298-311.
  149. Jennifer L. Kohn & Jing Shi Liu, 2013. "The Dynamics Of Medical Care Use In The British Household Panel Survey," Health Economics, John Wiley & Sons, Ltd., vol. 22(6), pages 687-710, June.
  150. Gonzalez, Eduardo T. & Urquico, Corazon & Beringuela. Maria Luisa, 1995. "Medicare I: Evaluation of Alternative Reform Measures," Discussion Papers DP 1995-17, Philippine Institute for Development Studies.
  151. Selder, Astrid, 2005. "Physician reimbursement and technology adoption," Journal of Health Economics, Elsevier, vol. 24(5), pages 907-930, September.
  152. Lakomaa, Erik & Sanandaji, Tino, 2021. "Exploring collective consumer innovation in health care: Cases and formal modeling," Research Policy, Elsevier, vol. 50(8).
  153. repec:hal:spmain:info:hdl:2441/4303 is not listed on IDEAS
  154. Gauri, Varun, 2001. "Are incentives everything? payment mechanisms for health care providers in developing countries," Policy Research Working Paper Series 2624, The World Bank.
  155. Davide Consoli & Andrea Mina, 2009. "An evolutionary perspective on health innovation systems," Journal of Evolutionary Economics, Springer, vol. 19(2), pages 297-319, April.
  156. Joy Grossman & Dwayne Banks, 1998. "Unrestricted Entry and Nonprice Competition: The Case of Technological Adoption in Hospitals," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 5(2), pages 223-245.
  157. Frédéric Rupprecht & Bruno Tissot & Frédéric Chatel, 1998. "Le système de santé allemand : vers une plus grande responsabilisation de l'ensemble des acteurs," Économie et Statistique, Programme National Persée, vol. 318(1), pages 17-40.
  158. Gonzalez, Eduardo T. & Urquico, Corazon & Canonizado, Edwin, 1995. "Evaluation of Medicare I: Administrative Issues," Discussion Papers DP 1995-07, Philippine Institute for Development Studies.
  159. Johnnesson, Magnus, 1995. "Economic evaluation of health care and policymaking," Health Policy, Elsevier, vol. 33(3), pages 179-190, September.
  160. Wong, Albert & Wouterse, Bram & Slobbe, Laurentius C.J. & Boshuizen, Hendriek C. & Polder, Johan J., 2012. "Medical innovation and age-specific trends in health care utilization: Findings and implications," Social Science & Medicine, Elsevier, vol. 74(2), pages 263-272.
  161. Bech, Mickael & Christiansen, Terkel & Dunham, Kelly & Lauridsen, Jørgen & Lyttkens, Carl Hampus & McDonald, Kathryn & McGuire, Alistair & TECH investigators, the, 2006. "How do economic incentives and regulatory factors influence adoption of cardiac technologies? Result from the TECH project," Working Papers 2006:15, Lund University, Department of Economics.
  162. Lakomaa, Erik & Sanandaji, Tino, 2017. "Can Community Driven Care be integrated in the European Welfare System? Institutional Challenges and Historical Lessons," SSE Working Paper Series in Economic History 2017:3, Stockholm School of Economics.
  163. Bianca Frogner, 2010. "The missing technology," Applied Health Economics and Health Policy, Springer, vol. 8(6), pages 361-371, November.
  164. repec:dau:papers:123456789/3883 is not listed on IDEAS
  165. Braendle, Thomas & Colombier, Carsten, 2020. "Budgetary targets as cost-containment measure in the Swiss healthcare system? Lessons from abroad," Health Policy, Elsevier, vol. 124(6), pages 605-614.
  166. Kamran Nayeri, 1995. "Economic Boundaries of Health Care: Factors Influencing Reform Proposals," Review of Radical Political Economics, Union for Radical Political Economics, vol. 27(4), pages 56-82, December.
  167. Volker Grossmann, 2021. "Medical Innovations and Ageing: A Health Economics Perspective," CESifo Working Paper Series 9387, CESifo.
  168. Maciej Lis, 2016. "Age or time-to-death – what drives health care expenditures? Panel data evidence from the OECD countries," IBS Working Papers 04/2016, Instytut Badan Strukturalnych.
  169. repec:bla:glopol:v:8:y:2017:i:s2:p:7-22 is not listed on IDEAS
  170. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," Journal of Economic Perspectives, American Economic Association, vol. 22(4), pages 27-50, Fall.
  171. Michel Dumont & Peter Willemé, 2013. "Working Paper 02-13 - Machines that go ‘ping’: medical technology and health expenditures in OECD countries," Working Papers 1302, Federal Planning Bureau, Belgium.
  172. OGLOBLIN, Constantin, 2011. "Health Care Efficiency Across Countries: A Stochastic Frontier Analysis," Applied Econometrics and International Development, Euro-American Association of Economic Development, vol. 11(1).
  173. Christian M. Ernst, 2003. "The interaction between cost‐management and learning for major surgical procedures – lessons from asymmetric information," Health Economics, John Wiley & Sons, Ltd., vol. 12(3), pages 199-215, March.
  174. Wagner, Gert G., 2006. "Ökonomie(sierung) und Bildung - Plädoyer für ein entspannteres Verhältnis," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 52(1), pages 43-51.
  175. Casper van Ewijk & Nick Draper & Harry ter Rele & Ed Westerhout, 2006. "Ageing and the sustainability of Dutch public finances," CPB Special Publication 61, CPB Netherlands Bureau for Economic Policy Analysis.
  176. Anlauf, Markus & Wigger, Berthold U., 1999. "Health insurance and consumer welfare : The case of monopolistic drug markets," Discussion Papers 565, Institut fuer Volkswirtschaftslehre und Statistik, Abteilung fuer Volkswirtschaftslehre.
  177. Noland, Robert & Quddus, Mohammed Abdul, 2002. "Improvements in medical care and technology and reductions in traffic-related fatalities in Great Britain," ERSA conference papers ersa02p079, European Regional Science Association.
  178. Charles I. Jones, 2016. "Life and Growth," Journal of Political Economy, University of Chicago Press, vol. 124(2), pages 539-578.
  179. Hirth, Richard A., 1999. "Consumer information and competition between nonprofit and for-profit nursing homes," Journal of Health Economics, Elsevier, vol. 18(2), pages 219-240, April.
  180. Pierre Azoulay & Ariel Fishman, 2020. "The Rise of For-Profit Experimental Medicine," NBER Working Papers 26892, National Bureau of Economic Research, Inc.
  181. Panos Kanavos & Olivier Wouters & Aris Angelis & David Tordrup & Panos Kanavos, 2017. "Is the Funding of Public National Health Systems Sustainable over the Long Term? Evidence from Eight OECD Countries," Global Policy, London School of Economics and Political Science, vol. 8, pages 7-22, March.
  182. Cooper, Samuel T. & Cohn, Elchanan, 1997. "Estimation of a frontier production function for the South Carolina educational process," Economics of Education Review, Elsevier, vol. 16(3), pages 313-327, June.
  183. Robert F. Graboyes, 2000. "Medicine worse than the malady : cure rates, population shifts, and health insurance," Working Paper 00-06, Federal Reserve Bank of Richmond.
  184. Gal-Or, Esther, 1994. "Excessive Investment in Hospital Capacities," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 3(1), pages 53-70, Spring.
  185. Vincenzo Atella & Joanna Kopinska, 2018. "New Technologies and Costs," CEIS Research Paper 442, Tor Vergata University, CEIS, revised 09 Aug 2018.
  186. Selden, Thomas M., 1999. "Premium subsidies for health insurance: excessive coverage vs. adverse selection," Journal of Health Economics, Elsevier, vol. 18(6), pages 709-725, December.
  187. Slade, Eric P. & Anderson, Gerard F., 2001. "The relationship between per capita income and diffusion of medical technologies," Health Policy, Elsevier, vol. 58(1), pages 1-14, October.
  188. Oliver Baumann & Hariolf Grupp, 2008. "Firm boundary decisions: the market for health-related R&D services with an empirical case study for Germany," International Economics and Economic Policy, Springer, vol. 5(3), pages 297-321, November.
  189. Strulik, Holger & Grossmann, Volker, 2024. "The economics of aging with infectious and chronic diseases," Economics & Human Biology, Elsevier, vol. 52(C).
  190. Anne E. Hall, 2015. "Adjusting the Measurement of the Output of the Medical Sector for Quality: A Review of the Literature," BEA Working Papers 0122, Bureau of Economic Analysis.
  191. Brian Nolan, 1994. "Affordability versus Quality, Effectiveness and Equity in Health Care: Is there a Trade-Off?," Papers WP055, Economic and Social Research Institute (ESRI).
  192. Böhm, Sebastian & Grossmann, Volker & Strulik, Holger, 2017. "The Future of Human Health, Longevity, and Health Costs," VfS Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking 168288, Verein für Socialpolitik / German Economic Association.
  193. Magnus Lindelow, 2003. "Understanding spatial variation in the utilization of health services: does quality matter?," Economics Series Working Papers WPS/2004-12, University of Oxford, Department of Economics.
  194. Walter M. Cadette, 1999. "Rethinking Health Care Policy: The Case for Retargeting Tax Subsidies," Macroeconomics 9902011, University Library of Munich, Germany.
  195. Peipei Chai & Quan Wan & Yohannes Kinfu, 2021. "Efficiency and productivity of health systems in prevention and control of non-communicable diseases in China, 2008–2015," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(2), pages 267-279, March.
  196. Blomqvist, A. G. & Carter, R. A. L., 1997. "Is health care really a luxury?," Journal of Health Economics, Elsevier, vol. 16(2), pages 207-229, April.
  197. Bruno Ventelou, 1999. "Les dépenses de santé des Français : une maladie d'amour?," Revue de l'OFCE, Programme National Persée, vol. 71(1), pages 247-280.
  198. Borger, Christine & Rutherford, Thomas F. & Won, Gregory Y., 2008. "Projecting long term medical spending growth," Journal of Health Economics, Elsevier, vol. 27(1), pages 69-88, January.
  199. Vincenzo Atella & Michael Hobbs & Steve Ridout & Jeff Richardson & Iain Robertson & Marie Closon & Julian Perelman & Konrad Fassbender & Jack Tu & Grant Curry & Peter Austin & Louise Pilote & Mark J. , 2003. "The Relationship Between Health Policies, Medical Technology Trends and Outcomes," Post-Print halshs-01990752, HAL.
  200. Faridah Djellal & Camal Gallouj & Faïz Gallouj & Karim Gallouj, 2004. "L'innovation à l'hôpital : une grille d'analyse et des études de cas," Working Papers hal-01111804, HAL.
  201. Astolfi, Roberto & Lorenzoni, Luca & Oderkirk, Jillian, 2012. "Informing policy makers about future health spending: A comparative analysis of forecasting methods in OECD countries," Health Policy, Elsevier, vol. 107(1), pages 1-10.
  202. Giuditta Callea & Aleksandra Torbica & Rosanna Tarricone, 2014. "Impatto del sistema di finanziamento a DRG sull?innovazione tecnologica in sanit?. Il caso italiano," MECOSAN, FrancoAngeli Editore, vol. 2014(89), pages 31-48.
  203. Pratt, John W & Zeckhauser, Richard J, 1996. "Willingness to Pay and the Distribution of Risk and Wealth," Journal of Political Economy, University of Chicago Press, vol. 104(4), pages 747-763, August.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.